Free Trial

This company has been marked as potentially delisted and may not be actively trading.

4D pharma (LBPS) Short Interest Ratio & Short Volume

4D pharma Short Interest Data

4D pharma (LBPS) has a short interest of 58,600 shares. This marks a -2.82% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 0 shares to cover all short positions.

Current Short Interest
58,600 shares
Previous Short Interest
60,300 shares
Change Vs. Previous Month
-2.82%
Dollar Volume Sold Short
$141.82 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
June 15, 2022
Today's Trading Volume
0 shares
Average Trading Volume
0 shares
Today's Volume Vs. Average
NaN
Short Selling 4D pharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for 4D pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LBPS Short Interest Over Time

LBPS Days to Cover Over Time

LBPS Percentage of Float Shorted Over Time

4D pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202258,600 shares $141.82 thousand -2.8%N/A0.1 $2.42
5/31/202260,300 shares $194.17 thousand -6.8%N/A0.2 $3.22
5/15/202264,700 shares $208.33 thousand -1.5%N/A0.2 $3.22
4/30/202265,700 shares $252.95 thousand -5.1%N/A0.2 $3.85
4/15/202269,200 shares $338.39 thousand -31.7%N/A0.2 $4.89
3/31/2022101,300 shares $489.28 thousand +163.1%N/A0.3 $4.83
3/15/202238,500 shares $167.86 thousand +3,108.3%N/A0.1 $4.36
2/28/20221,200 shares $4.03 thousand -42.9%N/A0.1 $3.36
2/15/20222,100 shares $7.43 thousand -67.7%N/A0.1 $3.54
1/31/20226,500 shares $25.87 thousand +132.1%N/A0.4 $3.98
1/15/20222,800 shares $12.57 thousand +250.0%N/A0.1 $4.49
12/31/2021800 shares $4.36 thousand +14.3%N/A0 $5.45
12/15/2021700 shares $3.86 thousand -66.7%N/A0 $5.52
11/30/20212,100 shares $12.64 thousand -30.0%N/A0.1 $6.02
11/15/20213,000 shares $26.61 thousand -55.2%N/A0.1 $8.87
10/29/20216,700 shares $43.75 thousand +13.6%N/A0.2 $6.53
10/15/20215,900 shares $44.25 thousand +15.7%N/A0.2 $7.50
9/30/20215,100 shares $31.42 thousand +15.9%N/A0.2 $6.16
9/15/20214,400 shares $34.72 thousand -57.7%N/A0.2 $7.89
8/31/202110,400 shares $101.09 thousand +2,500.0%N/A0.5 $9.72
8/13/2021400 shares $3.61 thousand No ChangeN/A0 $9.03

LBPS Short Interest - Frequently Asked Questions

What is 4D pharma's current short interest?

Short interest is the volume of 4D pharma shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 58,600 shares of LBPS short. Learn More on 4D pharma's current short interest.

Is 4D pharma's short interest increasing or decreasing?

4D pharma saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 58,600 shares, a decrease of 2.8% from the previous total of 60,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does 4D pharma's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to 4D pharma: Calithera Biosciences, Inc. (0.43%), Clever Leaves Holdings Inc. (0.52%), Cocrystal Pharma, Inc. (0.07%), CytoMed Therapeutics Limited (1.20%), Eloxx Pharmaceuticals, Inc. (0.08%), and

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.58 billion), Occidental Petroleum Corporation ($3.23 billion), Lucid Group, Inc. ($2.31 billion), Coinbase Global, Inc. ($1.73 billion), Snowflake Inc. ($1.71 billion), Chesapeake Energy Co. ($1.66 billion), Rivian Automotive, Inc. ($1.63 billion), Williams-Sonoma, Inc. ($1.51 billion), Lumen Technologies, Inc. ($1.40 billion), and Diamondback Energy, Inc. ($1.37 billion). View all of the most shorted stocks.

What does it mean to sell short 4D pharma stock?

Short selling LBPS is an investing strategy that aims to generate trading profit from 4D pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against 4D pharma?

A short squeeze for 4D pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LBPS, which in turn drives the price of the stock up even further.

How often is 4D pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LBPS, twice per month. The most recent reporting period available is June, 15 2022.




This page (NASDAQ:LBPS) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners